ArticleBMC plant biology2026
Integration of HMW-GS and retrotransposon marker LTR14 for selection of wheat genotypes combining baking quality and resistance to take-all disease.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImproving bread wheat genotypes that combine durable resistance to take-all disease with high yield and favorable baking quality is an important objective in wheat breeding programs.
resultsIn this study, 97 bread wheat genotypes were selected from an initial collection of 1000 accessions based on previous phenotypic evaluations to ensure broad agronomic and quality-related diversity. In addition, three control cultivars (Roshan, Kavir, and Sardari) were included in the evaluation. These genotypes and control cultivars were evaluated for high molecular weight glutenin subunit (HMW-GS) composition, agronomic traits, disease severity (DS), and baking quality (BQ). SDS-PAGE analysis identified 11 HMW-GS, among which 5 + 10 (Glu-D1), 2* (Glu-A1), and 17 + 18 (Glu-B1) were associated with superior baking quality. The retrotransposon-based marker LTR14, previously associated with reduced disease severity, was excised, purified, and sequenced (NCBI GenBank accession number PX660489.1). Sequence analysis revealed partial similarity to γ-gliadin- and storage protein activator-related sequences. Correlation analysis showed a significant negative association between LTR14 and DS (r = -0.405, p < 0.05) and a positive association with lignin content (r = 0.310, p < 0.05). Heatmap clustering divided the genotypes into six groups, among which clusters 3 and 6 exhibited favorable combinations of low disease severity, high baking quality, desirable yield components, and the presence of LTR14 and favorable HMW-GS alleles. Principal component analysis explained 76.2% of the total variation, with PC2 positively associated with baking quality and grain yield traits and negatively associated with disease severity. Using the TOPSIS-based similarity index to the best conditions (SIB ≥ 0.75), nine genotypes were identified as promising candidates with favorable combinations of disease resistance, baking quality, and agronomic performance.
conclusionsThe results provide preliminary sequence-based characterization of the LTR14 retrotransposon-derived marker associated with reduced disease severity and suggest possible relationships with storage protein-related genomic regions. The integrative multi-trait framework applied in this study provides a preliminary strategy for identifying promising wheat genotypes for marker-assisted breeding programs targeting disease resistance, grain quality, and agronomic performance. However, it is important to emphasize that the study was conducted under a single environmental condition and sequence characterization was based on only one resistant genotype. Therefore, the observed associations must be considered preliminary, and substantial further multi-environment validation and broader sequencing analyses are essential to confirm the stability and broader applicability of these findings before any practical recommendations can be made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.